These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 740272)

  • 1. [Use of calcium 2,2'-disulfohexanoate in chronic hepatopathies].
    Ortolan A; Martin A; Pieropan G
    Minerva Dietol Gastroenterol; 1978; 24(1):7-11. PubMed ID: 740272
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effects of calcium-2,2'-disulfohexanoate in hepatic cirrhosis].
    Cangiano C; Angelico M; Rossi Fanelli F
    Clin Ter; 1978 Aug; 86(4):337-53. PubMed ID: 737963
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of the activity of calcium-2,2'-disulfohexanoate in liver insufficiency].
    Romboli L; Leonardi R; Bertucci P; Fortunati P
    Clin Ter; 1978 Nov; 87(3):265-72. PubMed ID: 753574
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatotropic action of calcium 2,2'-disulfohexanoate].
    Ferrari B; Della Seta L; Boscaini M; Piccini Leopardi M
    Clin Ter; 1978 Apr; 85(2):163-72. PubMed ID: 657746
    [No Abstract]   [Full Text] [Related]  

  • 5. [Calcium-2,2'-disulfohexanoate in the treatment of liver diseases: study of a series of 15 patients].
    Piludu G; Perpignano G
    Clin Ter; 1981 May; 97(4):377-82. PubMed ID: 7249568
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in some blood chemical parameters in patients with chronic liver diseases treated with calcium-2,2'-disulfohexanoate].
    Turpini R; Scotti A; Brusoni V; Perego M
    Clin Ter; 1980 Jun; 93(6):689-94. PubMed ID: 7428323
    [No Abstract]   [Full Text] [Related]  

  • 7. [Calcium-2, 2'-disulfo-hexanoate in the treatment of chronic hepatitis].
    Ninno ED; Tronaghi G; Idèo
    Clin Ter; 1975 Nov; 75(3):257-71. PubMed ID: 776508
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of acute and chronic liver diseases with calcium-2,2'-disulfohexanoate].
    Ravetta A
    Clin Ter; 1979 Aug; 90(4):357-68. PubMed ID: 262631
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of therapeutic activity of a new pharmacologic combination in patients with chronic liver and debilitating diseases].
    Pasotti C; Buniva G; Carpinella G
    Clin Ter; 1971 Mar; 56(5):427-39. PubMed ID: 5564990
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of calcium 2,2'-disulfohexanoate on the course of acute viral hepatitis: double-blind study].
    Calonghi G; Sueri L
    Clin Ter; 1982 Nov; 103(3):273-82. PubMed ID: 6759010
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of the short-term treatment of active chronic liver diseases with betamethasone].
    Sarti F; Milandri GL; Giuliani Piccari G; Formica G; Spongano P; Accardo P
    G Clin Med; 1982 Jun; 63(6):392-400. PubMed ID: 6816654
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of therapy in chronic liver diseases. Double-blind study with cianidanol].
    Machalke K; Müller B
    Fortschr Med; 1982 Apr; 100(14):665-7. PubMed ID: 6123478
    [No Abstract]   [Full Text] [Related]  

  • 13. [Controlled double-blind study of the effects of cycloxilic acid on hepato-biliary function].
    Rosselli M; Cavrini P
    Clin Ter; 1978 Sep; 86(5):465-84. PubMed ID: 367682
    [No Abstract]   [Full Text] [Related]  

  • 14. [Double-blind clinical evaluation of choleretic agents in patients with chronic liver disease and cholestasis syndromes].
    Alkabes M; Ancona A; Palmieri R; Palmieri G; Zambruno E
    Clin Ter; 1980 Dec; 95(6):637-54. PubMed ID: 7011665
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the action of a total liver extract in subacute and chronic hepatopathies].
    Bazzicalupo G; Coscelli C
    Minerva Med; 1968 Sep; 59(76):3977-82. PubMed ID: 5698739
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of chronic hepatopathies with phosphorylcholine and pantethine].
    Proietti C; Imperiale A; Chiti D
    Clin Ter; 1984 Aug; 110(3):251-7. PubMed ID: 6237863
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative clinical study of betamethasone-17-valerate cream and fluocortolone-fluocortolone-21-capronate cream].
    Pfitzer G; Schröter R
    Hautarzt; 1971 Jul; 22(7):299-305. PubMed ID: 4398241
    [No Abstract]   [Full Text] [Related]  

  • 18. [Alphamercaptopropionylglycine in chronic hepatopathies].
    Cacciari G; Malaguti P; Zincati GC
    Policlinico Med; 1972; 79(3):165-73. PubMed ID: 5051108
    [No Abstract]   [Full Text] [Related]  

  • 19. [Controlled clinical trial of a new combination of phosphorylcholine, homocysteine-gamma-thiolactone and vitamin B 12 in the parenteral treatment of chronic hepatopathies].
    Bandini S; Monteforte S
    Clin Ter; 1974 Jun; 69(6):549-60. PubMed ID: 4845637
    [No Abstract]   [Full Text] [Related]  

  • 20. [Trofopar treatment of chronic diffuse diseases of the liver].
    Loginov AS; Nikolaeva AP; Bendikov EA; Blok IuE; Sukhareva GV
    Sov Med; 1989; (7):79-81. PubMed ID: 2799537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.